Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>Mapatumumab

Mapatumumab

Mapatumumab Structure
Mapatumumab structure
CAS No.
658052-09-6
Chemical Name:
Mapatumumab
Synonyms
Mapatumumab;Research Grade Mapatumumab;Mapatumumab (anti-TNFRSF10A);Research Grade Mapatumumab (DHA05901)
CBNumber:
CB61508604
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-04-24 14:58:15
Request For Quotation

Mapatumumab Properties

form Liquid
color Colorless to light yellow
FDA UNII WZ1025JPGR
NCI Dictionary of Cancer Terms mapatumumab
NCI Drug Dictionary mapatumumab

Mapatumumab price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0620876 Mapatumumab 97.85% 658052-09-6 1mg $325 2026-06-04 Buy
ChemScene CS-0620876 Mapatumumab 97.85% 658052-09-6 5mg $975 2026-06-04 Buy
ChemScene CS-0620876 Mapatumumab 97.85% 658052-09-6 10mg $1571 2026-06-04 Buy
aablocks AA00FGUF Mapatumumab ≥95%(SDS-PAGE&SEC-HPLC) 658052-09-6 1mg $664 2026-05-28 Buy
aablocks AA00FGUF Mapatumumab ≥95%(SDS-PAGE&SEC-HPLC) 658052-09-6 5mg $2000 2026-05-28 Buy
Product number Packaging Price Buy
CS-0620876 1mg $325 Buy
CS-0620876 5mg $975 Buy
CS-0620876 10mg $1571 Buy
AA00FGUF 1mg $664 Buy
AA00FGUF 5mg $2000 Buy

Mapatumumab Chemical Properties, Uses, Production

Uses

Treatment of cancer.

in vivo

Mapatumumab (10 mg/kg; i.p. for three times) controls tumor growth when combined with irradiation[3].

Animal Model:Colo205-xenograft–bearing NMRI (nu/nu) nude mice[3]
Dosage:10 mg/kg
Administration:Intraperitoneal injection; 10 mg/kg; on days 1, 4, and 8
Result:Showed no significant differences when used alone, but when combined with irradiation (5×3 Gy, d1–5) showed a pronounced tumor regrowth-delay.

Mapatumumab Preparation Products And Raw materials

Raw materials

Preparation Products

Mapatumumab Suppliers

Global Suppliers ( 17)
Supplier Tel Email Country ProdList Advantage
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10305 58
NCE Biomedical Co.,Ltd. 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 China 1490 55
LETOPHARM LIMITED +86-21-5821 5861 sales@letopharm.com China 2374 58
SPIRO PHARMA eric_feng1954@126.com China 9239 55
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62
TargetMol Chemicals Inc. 4008200310 15002144251 marketing@tsbiochem.com China 24951 58
Biolab Reagents 027-65279366 18108604356 products@biolabreagent.com China 9864 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139 orders@jknbiochem.com China 7283 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
Supplier Advantage
Wuhan Chemstan Biotechnology Co., Ltd. 58
NCE Biomedical Co.,Ltd. 55
LETOPHARM LIMITED 58
SPIRO PHARMA 55
Shanghai YuanYe Biotechnology Co., Ltd. 60
ShangHai Biochempartner Co.,Ltd 62
TargetMol Chemicals Inc. 58
Biolab Reagents 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 58
Shanghai Yifei Biotechnology Co. , Ltd. 58

658052-09-6 (Mapatumumab) Related Search:

Manelimab Fasinumab Uliledlimab Suvizumab Etokimab
Necitumumab Polatuzumab vedotin Bemarituzumab Libivirumab Leronlimab

1of2

Mapatumumab Research Grade Mapatumumab (DHA05901) Research Grade Mapatumumab Mapatumumab (anti-TNFRSF10A) 658052-09-6